NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Methadone Hydrochloride的市場規模:各處方、用途、給藥途徑、流通管道、地區 - 佔有率,預測,及機會分析(2020年∼2027年)

Methadone Hydrochloride Market, by Formulation, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 980027
出版日期 內容資訊 英文 180 Pages
商品交期: 2-3個工作天內
價格
Methadone Hydrochloride的市場規模:各處方、用途、給藥途徑、流通管道、地區 - 佔有率,預測,及機會分析(2020年∼2027年) Methadone Hydrochloride Market, by Formulation, by Application, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月28日內容資訊: 英文 180 Pages
簡介

為了在全球Methadone Hydrochloride市場上強化地位,主要企業以合併和收購為焦點。2016年5月,Hikma Pharmaceuticals PLC收購RoxaneLaboratories, Inc製藥企業。據此收購,從Roxane Laboratories, Inc獲得Methadone Hydrochloride,擴大鴉片受體活化劑的產品系列。

本報告提供全球Methadone Hydrochloride市場的相關調查,市場規模和佔有率,機會和趨勢,成長及阻礙因素,各劑型、用途、給藥途徑、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告概要
  • 市場定義和範圍
  • 摘要整理
  • 市場概述:各劑型
  • 市場概述:各用途
  • 市場概述:各給藥途徑
  • 市場概述:各流通管道
  • 市場概述:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 成長要素與阻礙因素
  • 市場機會
  • 影響分析
  • 最近的產品銷售與核准
  • 開發平台分析
  • 品牌分析
  • 法規方案
  • PEST分析
  • 流行病學
  • 償付方案
  • 取得
  • 市場趨勢

第4章 COVID-19大流行的影響

  • 經濟影響
  • 研究開發
  • 政府分析

第5章 市場分析:各劑型(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢
    • 錠劑
    • 液體

第6章 市場分析:各用途(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢
    • 鴉片戒斷症狀
    • 慢性疼痛

第7章 市場分析:各給藥途徑(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢
    • 口服
    • 靜脈注射

第8章 市場分析:各流通管道(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第9章 市場分析:各地區(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭情形

  • 企業簡介
    • Eli Lilly and Company
    • Sanofi SA
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Tianjin Central Pharmaceutical Co., Ltd
    • Temad Co
    • Embio LTD
    • Harman Finochem Ltd
    • Rusan Pharma Ltd
目錄

Title:
Methadone Hydrochloride Market, by Formulation (Tablet, Solution, and Others), by Application (Opiate Withdrawal, Chronic Pain, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.

Market Dynamics

Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc

Key features of the study:

  • This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
  • This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
  • It profiles leading players in the global methadone hydrochloride market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
  • Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
  • The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market

Detailed Segmentation:

  • Global Methadone Hydrochloride Market, By Formulation :
    • Tablet
    • Solution
    • Others
  • Global Methadone Hydrochloride Market, By Application:
    • Opiate Withdrawal
    • Chronic Pain
    • Others
  • Global Methadone Hydrochloride Market, By Route of Administration :
    • Oral
    • Intravenous
  • Global Methadone Hydrochloride Market, By Distribution Channel :
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Methadone Hydrochloride Market, By Region:
    • North America
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Formulation :
      • Tablet
      • Solution
      • Others
      • By Application:
      • Opiate Withdrawal
      • Chronic Pain
      • Others
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel :
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Eli Lilly and Company *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Sanofi S.A
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt Pharmaceuticals
    • Siegfried Holding AG
    • Johnson Matthey
    • Tianjin Central Pharmaceutical Co., Ltd
    • Temad Co
    • Embio LTD
    • Harman Finochem Ltd
    • Rusan Pharma Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Formulation
  • Market Snapshot, By Application
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers and Restraints
  • Opportunities
  • Impact Analysis
  • Recent Product launches and Approvals
  • Pipeline Analysis
  • Brand Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Epidemiology
  • Reimbursement Scenario
  • Acquisition
  • Market Trend

4. Global Methadone Hydrochloride Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Research and Development
  • Government Analysis

5. Global Methadone Hydrochloride Market, By Formulation, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

6. Global Methadone Hydrochloride Market, By Application, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Opiate Withdrawal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Chronic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

7. Global Methadone Hydrochloride Market, By Route of Administration, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

8. Global Methadone Hydrochloride Market, By Distribution Channel, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

9. Global Methadone Hydrochloride Market, By Region, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Formulation, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Application 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Company Profiles
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Hikma Pharmaceuticals PLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mallinckrodt Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Siegfried Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson Matthey
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Tianjin Central Pharmaceutical Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Temad Co
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Embio LTD
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Harman Finochem Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rusan Pharma Ltd
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies